An observational study in ST-segment Elevation Myocardial Infarction (STEMI), sponsored by Renmin Hospital of Wuhan University. Completed at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-12-20.
Sponsored by Renmin Hospital of Wuhan University · Observational
The purpose of this study is to develop a risk score to predict the risks of in-hospital major adverse cardiac events in ST-segment elevation myocardial infarction patients treated by primary percutaneous coronary intervention.
The CSPR trial is an observational clinical trial to derive and validate a readily useable risk score to identify patients at high risk of in-hospital major adverse cardiac events in 5594 patients presenting with a ST-segment elevation myocardial infarction and treated by primary percutaneous coronary intervention.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's enrollment of 5,594 is above the median of 500 across 983 observational studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Renmin Hospital of Wuhan University is the lead sponsor of 83 studies on the registry; 27 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients with STEMI were treated by primary percutaneous coronary intervention at 7 large centers from central China.
Exclusion Criteria:
Data from Renmin Hospital of Wuhan University, The First College of Clinical Medical Science, China Three Gorges University, The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Xiangyang No.1 People's Hospital，and Wuhan Third Hospital will be used as a derivation cohort.
Other: no intervention
Data from The First Affiliated Hospital of Dalian Medical University and Jiangxi Provincial People's Hopital will be used as a derivation cohort.
Other: no intervention
no intervention
in-hospital acute de novo heart failure
Killip class ≥II
Time frame: in-hospital outcome, until discharge
cardiogenic shock
according to the universal definition
Time frame: in-hospital outcome, until discharge
death
according to the universal definition
Time frame: in-hospital outcome, until discharge
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Renmin Hospital of Wuhan University